Repeated transcranial direct current stimulation (tDCS) in nondepressed
  reduces levels of reported negative affects from daily stressors by Austin, Adelaide et al.
Prefrontal electrical stimulation in nondepressed reduces 
levels of reported negative affects from daily stressors 
 
Adelaide Austin a, Gabriela Jiga-Boy a, c, Sara Rea a, Simon Newstead a, Sian Roderick b, c, 
Nick J Davis a, R. Marc Clement b, and Frédéric Boy a, b, c 
a Department of Psychology, College of Human and Health Science, Swansea University, 
Wales | b Scientia Research Group | School of Medicine, Swansea University, Wales |c 
NeuroTherapeutics Limited, Institute of Life Science, Swansea University, SA2 8PP 
Swansea, Wales, 
Contributions: SR, AA, FB collected data; SR, FB analysed data; FB, SR, ND, SN, RMC, 
GJB wrote or commented on different versions of the manuscript  
Abstract 
Negative emotional responses to the daily life stresses have cumulative effects which, in 
turn, impose wide-ranging negative constraints on emotional well being and 
neurocognitive performance (Kalueff:2007cp, Charles:2013eq, Nadler:2010hk). Crucial 
cognitive functions such as memory and problem solving, as well more short term 
emotional responses (e.g., anticipation of- and response to- monetary rewards or losses) 
are influenced by mood. The negative impact of these behavioural responses is felt at the 
individual level, but it also imposes major economic burden on modern healthcare 
systems. Although much research have been undertaken to understand the underlying 
mechanisms of depressed mood and design efficient treatment pathways, comparatively 
little was done to characterize mood modulations that remain within the boundaries of a 
healthy mental functioning. In one placebo-controlled experiments, we applied daily 
prefrontal transcranial Direct Current Stimulation (tDCS) at five points in time, and 
found reliable improvements on self-reported mood evaluation. We replicated this 
finding in an independent double-blinded placebo-controlled experiment and showed 
that stimulation over a shorter period of time (3 days) is sufficient to create detectable 
mood improvements. Taken together, our data show that repeated bilateral prefrontal 
tDCS can reduce psychological distress in nondepressed individuals.  
1. Introduction 
One function of the dorsolateral prefrontal cortex (dlPFC) is to continuously 
appraise the emotional content of daily-life situations, and to rapidly regulate oriented 
responses (Levesque et al., 2003, Banks et al., 2007). The strong negative impact of daily 
stressors on current mood is well known (Bolger et al., 1989). Over time, the outcomes of 
this idiosyncratic evaluative and responsive process amass, and impact individuals’ 
emotional wellbeing and neurocognitive performance (Charles et al., 2013, Nadler et al., 
2010). Here, we exploited the modulation of GABA- and glutamate-ergic 
neurotransmission (Stagg et al., 2011a; Stagg et al., 2011b; Stagg et al., 2009, Kim et al., 
2014} and cortical excitability (Romero Lauro et al., 2014) caused by tDCS to determine 
whether negative emotional responses to daily-life stresses can be reduced in healthy 
individuals. tDCS involves placing two macro-electrodes on the scalp, and passing a 
weak regulated direct current (in the order of the mA) between them. Recent evidence 
from clinical research shows that repeated prefrontal tDCS in depressed patients 
produces measurable clinical benefits. Meta-analyses of recent open-label studies and 
double-blinded trials for the treatment of major depressive disorder (Brunoni et al., 2011a, 
DellOsso et al., 2012, Boggio et al., 2008; Fregni et al., 2006a; Fregni et al., 2006b, Loo et 
al., 2012; Loo et al., 2010), found that active prefrontal tDCS was associated, on average, 
with a 29.1% ± 4.6% reduction in depressive symptoms; and five of these studies 
detected long-lasting benefits a month after the last stimulation. In addition, Brunoni et al. 
(2011b) also found that 1- active tDCS was more effective than sham, 2- tDCS was as 
effective as Sertraline, a selective serotonin reuptake inhibitor (SSRI) antidepressant  and, 
3- tDCS and SSRI combined have greater efficacy than each treatment alone. This body 
of evidence strongly suggest that repeated daily prefrontal tDCS can be an effective tool 
for improving mood in depressed patient.  
However, the present challenge is to understand the neurobiological underpinnings 
and the psychological mechanisms at play in this effect. Here, we took the original 
approach of studying how repeated prefrontal tDCS modulated the way nondepressed 
volunteers self-evaluated the emotional states consequent to life events (stressful or not). 
This is particularly relevant since one of the leading causal factors in depression onset is 
the accumulation of negative emotional states resulting from sustained or chronic 
exposure to stressful life events (Gandiga et al., 2006).  
 
2. Methods 
a. Participants. 
Sixty-six early-adults, unmedicated, nondepressed females from Swansea University 
(mean age: 21.6 years ± 2.3, mainly Caucasian) participated in the experiments reported 
here in exchange of payment (£20) or course credit. All were naïve to the purpose of the 
experiments and had no neuropsychiatric history. Participants were aware that the 
experimental manipulation repeatedly used tDCS neuromodulation and that they would 
have to complete several questionnaires, but no further specification was given as to the 
nature of the hypotheses. The departmental Research Ethics Committee approved all 
procedures. After completion of experiment 1, two participants voluntarily reported 
significant events that affected their current mood (passing of a relative, relationship 
breakup), and their data were discarded. 
b. Bilateral prefrontal tDCS. 
A DC stimulator (HDCStim, Newronika, Milano, Italy) delivered a 1500 mA current to 
the scalp via 5x5 cm rubber-graphite electrodes (current density: 0.06 mA/cm2). 
Impedance was automatically monitored every 5s, and tension adjusted accordingly, so 
that to deliver constant current (within safety limits). In experiment 1 and 2 the anode 
was centred over the left F3 10-20 position (see Fig. 1). The cathode was placed over the 
contralateral F4 position (for similar electrodes placement see (Brunoni et al., 2011b, 
Dell’Osso et al., 2012). Sponges soaked in 0.9% NaCl solution (Sterowash, Steroplast, 
Manchester, UK) were used to create a conducting medium between the scalp and 
electrodes. For active stimulation, the current was ramped up over 15 seconds and was 
then held at 1500mA for 12 minutes, before being ramped down over 15s. For sham 
stimulations, the stimulator was automatically switched off after an initial ramp-up (15s at 
0.1 mA.s-1), plateau periods (6s at 1.5 mA), and final ramp-down (15s at -0.1 mA.s-1), to 
create a realistic placebo control condition (Brunoni et al., 2012) that still generate the 
short lasting tingling sensations identical to that felt at the beginning of the active tDCS 
stimulations. Usually, only these very mild sensations are experienced (Gandiga et al., 
2006), and when directly asked, most participants do not even perceive a difference 
between active and sham stimulation (Poreisz et al., 2007}. Experiment 1 was single 
blinded, whereas Experiment 2 was a double-blind randomized trial, where neither 
participants, nor experimenters knew whether the stimulation was active or sham. 
  
 
 
Figure 1 | a, Positioning of the stimulating scalp electrodes according to the 10-20 
system nomenclature, and in reference to the main cortical fissures b, 3D numerical 
computation of electric fields on the surface of a cortical model for 5 x 5 cm electrodes 
placed on F3 and F4 head locations (Jung et al., 2013) c, Timelines of experiments. 
c. Mood Assessment  
The Profile Of Mood States (Pollock et al., 1979) questionnaire provides a rapid method 
of assessing transient, fluctuating active mood states. It is an instrument that is 
particularly well suited to the present research because of its sensitivity to change in 
affective states. We used the abridged scale - a 24-item questionnaire that measures 
mood along six dimensions: tension-anxiety, depression-dejection, anger-hostility, 
vigour-activity, fatigue-inertia, and confusion-bewilderment (Curran et al, 2006). 
Participants rated how they were currently feeling with respect to 24 words (e.g., Worn-
out, Annoyed, Confused, Active, Panicky, Unhappy) on a scale of 1 (“Not at all”) to 5 
(“Extremely”). Scores at each of the factor scores, except for the vigour-activity score, 
was added together; and then, the vigour-activity score was then subtracted from this 
total to produce a general composite mood score. In Experiment 1, although participants 
received tDCS daily over five days, we limited the number of post-stimulation mood 
assessments by only administering the POMS every other day. In Experiment 2, where 
participants were stimulated daily over three days, we administered the POMS 
immediately after every stimulation (see Fig 1).  
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3. Results 
In two experiments, we present converging evidence that series of daily bilateral 
prefrontal tDCS sessions positively impacted the self-assessment of mood states. In 
Experiment 1, we first established that, when five 12 mn daily tDCS sessions were 
administered, scores at the Profile of Mood States scale were improved in the active (p < 
1.1e-05, Fig. 1a), but not in the sham condition (p = NS, Fig. 1b). In the active condition, 
significant improvements were found between evaluations carried out each other day (all 
ps < 0.01), whereas no change was noted between sham sessions (p = NS). This striking 
dichotomy was independently replicated in Experiment. 2, where tDCS sessions were 
administered on three consecutive days (active: p <1.55e-06, Fig. 2c; sham: p =NS, Fig. 
2d).  In substantive terms, the reduction in negative mood states, in the two active tDCS 
conditions, accounted for 64.7% and 39.1% of the total variations in scores in Expt. 1 
and 2, respectively.  
The absence of significant mood changes in the sham condition, where participants 
received series of 36s 1.5 mA daily stimulations, insured that the observed negative mood 
reduction was not due to a learning or habituation effect, with participants (consciously 
or unconsciously) gradually providing less negative ratings during the mood evaluation.  
 
 Figure 2 | a, b, Evolution of mood states self-evaluation (total score) throughout the 
three days of brain stimulation in the active, and the “sham” conditions. Grey line 
present individual performances in each condition. c, d, Similar plots for replication 
experiment 2. 
The general tendency towards mood improvement during active tDCS evidenced in 
the reduction in general composite mood score is logically resulting from improvements 
in each of the subscales. Although the design of the present research is not adapted to 
such subsampling of the data, we decided to still present how scores at each of the six 
subscales in the POMS were modulated by tDCS, without presenting any result of 
statistical testing (Fig. 3). Although the argument is only descriptive, and variability is 
high, we note that, for each scale except “vigour”, there is an amelioration tendency (a 
decrease in scores) in the active tDCS but not in the Sham condition. Our current 
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research programme explores this aspect of these datasets, in an adapted research 
protocol with sufficient statistical power. 
 
 
Figure 3 | a:f, Evolution of self-evaluation for each dimensions of the POMS 
throughout the three days of brain stimulation in the active and sham conditions in 
experiment 1. 
 
 
 
 
4. Discussion 
In two sham-controlled experiments, we found that repeated daily prefrontal tDCS 
sessions over 5 several days could effectively modulate how nondepressed individuals 
self assess their mood states. Results show that participants experienced less 
psychological distress from daily stressors, a well established cause in the establishment 
of a negative emotional state (Bolger et al., 1989). We replicated this finding in an 
independent, randomized, double-blind experiment applying similar protocol and 
stimulation on 3 consecutive days. 
To our knowledge, the present research is the first to show that the amount 
negative mood states, in unmedicated nondepressed individuals, can be reduced with 
repeated prefrontal tDCS. This is consistent with prior clinical body of research 
demonstrating that repeated tDCS improves depressive symptoms. Although, there are 
limited by a small number of studies with small sample size, the most recent systematic 
reviews to date (Meron et al., 2015;  Kalu et al., 2012) reach nonetheless the conclusion 
that tDCS significantly reduces symptoms of major depressive episodes. It is also true 
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that a few conflicting studies failed to find a reduction in psychological distress following 
prefrontal tDCS. However, the body of research in question either examined individuals 
with treatment-resistant depression, or else participant samples that were concurrently 
taking various medication treatments known to interact with tDCS (Loo et al., 2010; 
Bennabi et al., 2015, Blumberger et al., 2012). For example, the administration of GABA-
agonist benzodiazepines (Lorazepam) delays, enhances and prolonges the elevation in 
cortical excitability resulting from anodal tDCS (Nitsche et al., 2004), while Serotonin 
Selective Reuptake Inhibitors such as Citalopram concurrently increases anodal effects, 
and transforms cathodal inhibition into facilitation (Bennabi et al., 2015, Nitsche et al. 
2009, Brunoni et al., 2013).  
Only a few other studies have examined the possibility of modulating mood 
using tDCS in healthy individuals, these however failed to detect notable effect (Koenigs 
et al., 2009, Plazier et al., 2012, Morgan et al., 2014). While it is difficult to discuss the 
absence of notable effect, we believe these could be accounted for by radically different 
research designs, stimulation programme, electrode montages, or in the way current 
mood was evaluated. For example, in both experiments reported here, participants 
underwent either 5 or 3 consecutive days of active (or sham) bifrontal tDCS, and our 
conclusions are therefore founded upon comparisons between an active group and a 
sham group, and self reported modulation of mood occurring across days. In contrast, 
Plazier et al.’s (2012) goals were rather different and the research was looking for 
alterations in mood, following a single session of tDCS, utilising six forms of bifrontal 
and bioccipital stimulation, upon the same participant. Although such an attempt is both 
interesting and commendable, it is difficult to conceive that biochemical alterations 
within the cortex or detectable effects on mood resulting from a single 20mn tDCS 
session would be of similar origins to mood modulation observed across days of 
repeated stimulation. Of importance, we also think that Plazier et al.’s (2012) way of 
administering mood questionnaires directly before and after the stimulation, is far from 
optimal: The short time period between repeated assessments, and a participants’ initial 
responses will likely have influenced, to some degree, latter responses to the 
questionnaires re-administered directly following stimulation. This observation regarding 
the limits of repeated questionnaire administration also applies to Morgan et al. (2014) 
and Koenigs et al., (2009) for the Positive Affect Negative Affect Schedule (PANAS), 
and the POMS, respectively. Of importance, Koenigs et al., (2009) rather placed the 
anode on the frontal poles bilaterally (Fp1 and Fp2), and used an extracephalic reference 
electrode, but detected no mood improvement after any of three usual tDCS conditions  
Discussion of certain methodological questions is needed to further inform 
future investigations.  For instance, our data may have implications for the interpretation 
of numerous findings in which prefrontal tDCS induces cognitive improvements (e.g., 
Kadosh et al., 2010, Jacobson et al., 2011}. Cognitive processing is affected by mood, 
with positive mood being associated with improved cognitive performance (Nadler et al., 
2010), and since we show that tDCS reduces self reported psychological distress, it is 
possible that tDCS-induced cognitive improvement are actually mediated by a mood 
improvement (or vice-versa). Current neuromodulatory work in our team address this 
issue, and aims at disentangling the complex interaction between mood and cognitive 
performance. Another pertinent issue relates to the duration of the tDCS-induced mood 
modulation. In clinical studies, researchers have reported mood improvement effects to 
be maintained for at least one month after the last stimulation  (Kalu et al., 2012. 
However, these studies involve a greater number of stimulation sessions (N = 10), over a 
longer period of time (two weeks), and that indicates that the optimal programme of 
stimulation needed to warrant a potentiated reduction of psychological distress in a non-
clinical population still has to be determined.  
 Both past studies in depression, and the present work indicate, respectively, that 
tDCS is effective in reducing depressive symptoms and psychological distress, 
respectively. An important question to consider concerns the identification of the 
neurophysiological mechanisms that are able to induce these changes. One possible 
explanation follows from two programmes of research. One that examined the 
relationship between GABA levels and depression, and evidenced that GABA-agonist 
drugs and agents all tend to ameliorate the depressive symptomatology in human, and in 
animals (Kalueff et al., 2007). Another, more recent body of research, showed that tDCS  
could lower cortical GABA and Glutamate level locally (Stagg et al., 2009). Although the 
latter effect was obtained in regions of the frontal cortex that are not directly causally 
related to mood regulation, unlike the dlPFC, we believe that it provides a general 
framework for the generation of testable hypotheses. The details of the interaction 
between GABAergic neuromodulation within the dlPFC and mood regulation are likely 
to be complex, as the dlPFC forms part of a network involving loops through striatum 
and thalamus as well as numerous connections to other cortical and subcortical areas 
relevant for regulating mood. Similarly, the apparent contradiction between the effect of 
a technique which lowers levels of GABA and a general GABA deficit theory in 
depression has to be understood in this context, and treated with great care. It is indeed 
possible that the tDCS-induced local reduction in GABA concentration results in 
potentiated GABAergic neurotransmission along these extended networks (for similar 
reasoning, see discussion in  Boy et al., 2011). 
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